Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/threshold level of specific pancreatic digestive enzymes to the intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies.

During the initial discussion, speakers will share best practices for:

• Identifying when to suspect EPI.
• Diagnosing EPI: utilizing current testing methods effectively.
• Effective management strategies for EPI.
  

The latter half of the session will feature a product theater, sponsored by AbbVie Inc. This segment will offer an overview of EPI in chronic pancreatitis (CP), current EPI diagnostic tools and challenges faced in diagnosing EPI. Additionally, attendees will be introduced to a new digital clinical screening tool through a live demonstration. This tool is designed to assist clinicians in evaluating patients with definite CP at risk for EPI.

Learning objectives for the product theater:

Provide background information on EPI in CP.

Discuss current EPI diagnostic tools and challenges.

Introduce and provide a live demonstration of a new digital clinical screening tool that was developed to help clinicians evaluate patients with definite CP at a risk for EPI.

Speakers:

David C. Whitcomb, MD, PhD
Professor of Medicine Emeritus
Division of Gastroenterology Hepatology and Nutrition (Chief 1999-2016)
University of Pittsburgh and UPMC

Anna M. Buchner, MD, PhD
Associate Professor of Medicine
University of Pennsylvania
Division of Gastroenterology and Hepatology



Christopher Forsmark, MD
Chief Professor of Medicine
Division of Gastroenterology, Hepatology & Nutrition
University of Florida

 

Product theater presenter:

Mohamed O. Othman, MD
Professor of Medicine
Gastroenterology and Hepatology
Baylor College of Medicine

 

Pricing:

Member	Nonmember
Free	Free

Original release date: Mar. 15, 2024

Expiration date: Mar. 15, 2025

---

Sponsor:

The Product Theater is sponsored by AbbVie Inc.